Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Aug 1;73(8):2186-2196.
doi: 10.1093/jac/dky179.

2018 update to the HIV-TRePS system: the development of new computational models to predict HIV treatment outcomes, with or without a genotype, with enhanced usability for low-income settings

Andrew D Revell  1 , Dechao Wang  1 , Maria-Jesus Perez-Elias  2 , Robin Wood  3 , Dolphina Cogill  3 , Hugo Tempelman  4 , Raph L Hamers  5 , Peter Reiss  5   6 , Ard I van Sighem  6 , Catherine A Rehm  7 , Anton Pozniak  8 , Julio S G Montaner  9 , H Clifford Lane  7 , Brendan A Larder  1 ; RDI Data and Study Group
Collaborators, Affiliations

2018 update to the HIV-TRePS system: the development of new computational models to predict HIV treatment outcomes, with or without a genotype, with enhanced usability for low-income settings

Andrew D Revell et al. J Antimicrob Chemother. .

Abstract

Objectives: Optimizing antiretroviral drug combination on an individual basis can be challenging, particularly in settings with limited access to drugs and genotypic resistance testing. Here we describe our latest computational models to predict treatment responses, with or without a genotype, and compare their predictive accuracy with that of genotyping.

Methods: Random forest models were trained to predict the probability of virological response to a new therapy introduced following virological failure using up to 50 000 treatment change episodes (TCEs) without a genotype and 18 000 TCEs including genotypes. Independent data sets were used to evaluate the models. This study tested the effects on model accuracy of relaxing the baseline data timing windows, the use of a new filter to exclude probable non-adherent cases and the addition of maraviroc, tipranavir and elvitegravir to the system.

Results: The no-genotype models achieved area under the receiver operator characteristic curve (AUC) values of 0.82 and 0.81 using the standard and relaxed baseline data windows, respectively. The genotype models achieved AUC values of 0.86 with the new non-adherence filter and 0.84 without. Both sets of models were significantly more accurate than genotyping with rules-based interpretation, which achieved AUC values of only 0.55-0.63, and were marginally more accurate than previous models. The models were able to identify alternative regimens that were predicted to be effective for the vast majority of cases in which the new regimen prescribed in the clinic failed.

Conclusions: These latest global models predict treatment responses accurately even without a genotype and have the potential to help optimize therapy, particularly in resource-limited settings.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Partition scheme. EVG, elvitegravir; MVC, maraviroc; TPV, tipranavir.
Figure 2.
Figure 2.
ROC curves for the NG models versus genotyping (GSS).
Figure 3.
Figure 3.
ROC curves for the G models versus genotyping (GSS).
See this image and copyright information in PMC

References

    1. WHO. HIV Drug Resistance Report 2017 www.who.int/hiv/pub/drugresistance/hivdr-report-2017/en/.
    1. Montaner JS, Lima VD, Harrigan PR. et al. Expansion of HAART coverage is associated with sustained decreases in HIV/AIDS morbidity, mortality and HIV transmission: the “HIV Treatment as Prevention” experience in a Canadian setting. PLoS One 2014; 9: e87872.. - PMC - PubMed
    1. Nkambule R, Nuwagaba-Biribonwoha H, Mnisi Z. et al. Substantial progress in confronting the HIV epidemic in Swaziland: first evidence of national impact. In: Abstracts of the Ninth IAS Conference on HIV Science, Paris, France, 2017. Abstract MOAX0204LB. International AIDS Society, Geneva, Switzerland.
    1. Günthard HF, Aberg JA, Eron JJ. et al. Antiretroviral treatment of adult HIV infection: 2014 recommendations of the International Antiviral Society–USA Panel. JAMA 2014; 312: 410–25. - PubMed
    1. Williams I, Churchill D, Anderson J. et al. British HIV Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2012. HIV Med 2014; 15 Suppl 1: 1–85. - PubMed

Publication types